ASSOCIATION OF VA HEMATOLOGY/ONCOLOGY - AVAHO by JBbAUr6

VIEWS: 9 PAGES: 5

									                               ASSOCIATION OF VA HEMATOLOGY/ONCOLOGY
                                          8th ANNUAL MEETING
                                          October 19 – 21, 2012
                                        Embassy Suites, Omaha, NE

                                            FINAL PROGRAM AGENDA

                                           FRIDAY, OCTOBER 19, 2012
1:00 – 6:00 pm        Registration
1:00 – 6:00 pm        Exhibitor Set-up
2:00 – 3:30 pm        AVAHO Board Meeting
3:00 – 5:30 pm        Tour of Omaha VA Medical Center (Transportation provided)
6:30 – 8:30 pm        AVAHO Reception (Durham Museum)
                      SPEAKER: Robert Kyle, MD “Update on Myeloma”

                                         SATURDAY, OCTOBER 20, 2012
7:00 – 5:00 pm        Registration
7:00 – 5:00 pm        Exhibit Displays
7:00 – 5:00 pm        General Poster Session
7:00 – 8:30 am        Breakfast Buffet
8:00 – 8:15 am        Welcome/Introduction
8:15—8:45 am          RADIATION ONCOLOGY
                      Michael Hagan, MD, PhD
                      National Director, Radiation Oncology
                      Veterans Health Administration

8:45 – 9:15 am        ACCESS AND COST OF RADIATION THERAPY IN THE VA
                      Robert Campbell, JD, PhD, MPH
                      James A. Haley VAMC
                      Tampa, FL

9:15 – 9:45 am        PROVIDING EXCELLENT PALLIATIVE CARE TO VETERANS WITH CANCER
                      Pam Malloy, MN, RN, FPCN
                      ELNEC Project Director and Co-Investigator, ELNEC-For Veterans
                      American Association of Colleges of Nursing (AACN)
                      Washington, DC

Objectives:       #1: Describe the unique culture of Veterans and how this impacts care at the end of their lives.
                  #2: Identify at least 3 barriers when providing care for the Veterans with life-limiting illness.
                  #3: Describe the role of palliative care and its benefits in caring for Veterans with life-limiting
                  illness.

9:45 – 10:15 am       Break/Exhibits

Last updated: 9/5/12                                                                                         1
10:15 – 10:45 am   TELEPATHOLOGY & TELE-TUMOR BOARD
                   Edward D. Adickes, DO
                   Creighton University, Omaha, NE

10:45 – 11:15 am   MOLECULAR DIAGNOSTICS IN SURGICAL PATHOLOGY
                   Heather Rojas, MD
                   Chief, Department of Pathology and Laboratory Medical Services
                   VA Loma Linda Healthcare System, Loma Linda, CA
Objectives:        1. Current molecular diagnostics in lung carcinoma, melanoma, and breast carcinomas
                   2. Optimal types of specimens for submission for molecular tests
                   3. What to look for in a molecular pathology report

11:15 – 12:00 pm   UPDATES SESSION
    11:15 am       QUALITY INITIATIVES IN THE VA
                   Michael J. Kelley, MD
                   National Program Director for Oncology, Department of Veterans Affairs,
                   Patient Care Services, Washington, DC

    11:30 am       FIELD ADVISORY COMMITTEE
                   Anna Schorer, MD
                   Minneapolis VAMC, Minneapolis, MN

    11:45 am       PHARMACY UPDATE
                   Mark Geraci, PharmD
                   Chicago, IL

12:00 – 2:00 pm    Lunch/Business Meeting
                   “UPDATE ON LYNCH SYNDROME”
                   Henry Lynch, MD
                   Chairman, Department of Preventive Medicine and Public Health, Creighton
                   University, Omaha, NE

2:00 – 2:30 pm     LUNG CANCER MANAGEMENT IN THE OLDER PATIENTS
                   Apar Kishor Ganti, MD
                   University of Nebraska Medical Center, Omaha, NE
Objectives:        1. Understand the differences between the physiology of older and younger patients with
                   lung cancer
                   2. Describe the differences in the management of older and younger patients with lung
                   cancer
                   3. Enumerate the treatment options for older patients with advanced lung cancer

2:30 – 3:00 pm     PROSTATE CANCER
                   Gurkamal Chatta, MD
                   Virginia Mason Medical Center, Seattle, WA

3:00 – 3:30 pm     PROSTATE CANCER STUDY
                   Theresa Wicklin Gillespie, PhD
                   Emory University and Atlanta VA Medical Center, Decatur, GA

Last updated: 9/5/12                                                                                2
Objectives:      1. To present the findings from the National VA Study of Prostate Cancer Care Quality
                 2. To interpret the results in the context of VA clinical care
                 3. To illustrate opportunities for quality improvement in prostate cancer care in the VHA

3:30 – 4:00 pm       PANEL DISCUSSION on prostate cancer

4:00 – 4:30 pm       WHAT’S NEW IN BMT: INTERESTING CASES
                     Stacey Goodman, MD
                     Director, Bone Marrow Stem Cell Transplant
                     TVHS Nashville Campus
                     Professor of Medicine, Vanderbilt University
Objectives:      1. To illustrate BMT cases will be presented some of the newer developments that have occurred
                 in the past 5-10 years
                 2. To learn about sources of stem cells—use of cord blood transplant and eligibility—age and
                 hematologic conditions
                 3. To understand the intensity of conditioning—use of reduced intensity conditioning

4:30 – 5:30 pm       POSTER SESSION
5:30 – 6:30 pm       BREAKOUT SESSIONS
       Breakout 1        Physicians (Moderator: Maria Ribeiro and Anna Schorer)
       Breakout 2        Nurses (Moderator: Lori Hoffman Hogg and Ellen Ballard)
       Breakout 3        Pharmacists (Moderators: Sean Cosgriff)
       Breakout 4        Registrars (Moderators: Donna Connery, Patty Coke, Margo St. Julien)
       Breakout 5        Psycho-social (Moderators: Kaki York and Aruna Gottumukkala)
6:30 – 7:30 pm       RECEPTION/EXHIBIT DISPLAYS
7:30 – 9:30 pm       ANNUAL DINNER/PRESIDENTIAL ADDRESS: Dr. Peter Silberstein
                     KEYNOTE SPEAKER: James Armitage, MD, Professor, Internal Medicine, Division of
                     Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE


                                         SUNDAY, OCTOBER 21, 2012
7:00 – 12:00 pm           Registration
7:00 – 12:00 pm           Exhibit Displays
7:00 – 12:00 pm           General Poster Session
7:00 – 8:30 am            Breakfast Buffet
8:00—8:30 am              Plenary Session
    8:00 am               MULTIPLE PRIMARY MALIGNANCES IN US VETERANS: ANALYSIS OF THE
                          MINNEAPOLIS VA TUMOR REGISTRY
                          S Powell, G Tarchand, T Rector, M Klein
                          Minneapolis VA Medical Center, Minneapolis, MN



Last updated: 9/5/12                                                                                     3
Objectives             1. Understand the incidence of multiple primary malignancies (MPMs) in Minneapolis
                       VAMC patients.
                       2. Appreciate the types of malignancies represented in patients with MPMs.
                       3. Evaluate differences in patients with synchronous and metachronous MPMs.

    8:15 am            VA CT CANCER CARE TRACKING SYSTEM – AN INNOVATIVE TOOL TO
                       FACILITATE CANCER CARE
                       T Taddei, L Hunnibell, A DeLorenzo, M Rosa, D Connery, D Vogel, V Garla, C
                       Taylor, M Rose
                       VA CT Healthcare System, West Haven, CT

8:30—9:30 am           Abstract Session
    8:30 am            SETTING THE BAR - IMPROVING CARE FOR HEAD AND NECK CANCER PATIENTS
                       IN THE VETERAN'S HEALTH ADMINISTRATION
                       R Shapiro, J Compton, H Fosmire
                       Roudebush VA Medical Center, Indianapolis, IN

    8:40 am            A NEW PORTABLE TELEHEALTH DEVICE FOR OTOTOXICITY MONITORING, THE
                       OTOID
                       M Dille, W Helt, S, G McMillan
                       National Center for Rehabilitative Auditory Research (NCRAR), VA Medical
                       Center, Portland, OR
Objectives             1: Participants will be able to describe the validation measurements used to determine if
                       the OtoID provided reliable measures on human subjects.
                       2: Participants will be able to describe the standard used to determine if a patient on
                       cisplatin chemotherapy has a significant hearing shift (ototoxic hearing shift).

    8:50 am            IMPACT OF RACE ON EARLY-STAGE LUNG CANCER TREATMENT AND
                       OUTCOME
                       CD Williams, D Provenzale, KM Stechuchak, MJ Kelley
                       Durham VA Medical Center, Durham, NC

    9:00 am            COMPARISON OF CLINICAL PARAMETERS AND SURVIVAL IN VIETNAM ERA (V)
                       VERSUS NON-VIETNAM ERA (NON-V) VETERANS WITH NON-HODGKIN
                       LYMPHOMA (NHL)
                       S Srinivas, VT Chang, L Cordero Floyd, B Kasimis, ML Gonzalez, M McPherson, J
                       Cogswell, B Crump, L Duque, ER Paz-Querubin
                       VA New Jersey Health Care System, East Orange, NJ; UMDNJ-New Jersey
                       Medical School

    9:10 am            TARGETING METABOLISM AND SIGNALING IN MELANOMA
                       N Savaraj
                       Miami VA Healthcare System, Miami, FL
Objective:             1. Understand the differences in metabolism between melanoma and normal cells.
                       These differences can be used to design treatment which can selectively kill tumor cells
                       with few side effects in normal cells.




Last updated: 9/5/12                                                                                   4
    9:20 am            OUTCOME OF MYELODYSPLASTIC SYNDROME IN VETERANS TREATED WITH 5-
                       AZACITIDINE AND DECITABINE
                       KS Abbas, A Li, GA Rivero, P Lulla, A Mulchandani, Z Yasin, S Yellapragada
                       Michael E DeBakey VAMC, Houston, TX

9:30 – 10:00 am        Break/Exhibits
10:00 – 10:30 am       COMMISSION ON CANCER
                       David H. Berger, MD
                       Chief of Surgery, Michael E. DeBakey Medical Center
                       Houston, TX

10:30 – 11:00 am       VHA CANCER SURVIVORSHIP SIG E-TOOL KIT
                       David Haggstrom, MD
                       Indianapolis, IN
Objectives:            1. Describe medical and psychosocial issues faced by cancer survivors and their relevance
                       to the Veteran population
                       2. Describe information technology and system tools that have been developed to meet
                       the needs of Veteran cancer survivors

11:00 – 11:30 am       PSYCHOSOCIAL ASSESSMENT OF CANCER PATIENTS
                       Kaki York, PhD, ABPP
                       Clinical Health Psychologist, and Associate Director of General Mental Health
                       Clinic
                       Aruna Gottumukkala, MD
                       Consultation and Liaison Psychiatrist, and Assistant Director for the Mental
                       Health Careline Houston VA Medical Center, Houston, TX
Objectives:            1. describe the literature detailing rates of mental health conditions in patients
                       undergoing cancer treatment
                       2. discuss specific policies impacting the decision about whether and when to screen
                       3. identify potential measures used for screening in this population.

11:30 – 12:00 pm       ORAL ANTICOAGULANT AGENTS
                       William Dager, PharmD., BCPS
                       UCDavis Medical Center, Sacramento, CA

12:00 pm               ADJOURN

12:00 - 1:30 pm        Board Meeting/Lunch




Last updated: 9/5/12                                                                                 5

								
To top